The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Apr 2014
Editorial CommentObesity prevention in Latin America: now is the time.
-
Lancet Diabetes Endocrinol · Mar 2014
Randomized Controlled TrialDirect iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial.
Iodine deficiency in infants can damage the developing brain and increase mortality. Present recommendations state that oral iodised oil should be given to breastfeeding mothers to correct iodine deficiency in infancy when iodised salt is not available, and that direct supplementation should be given to infants who are not being breastfed or receiving iodine-fortified complimentary foods. However, there is little evidence for these recommendations. We aimed to assess the safety and efficacy of direct versus indirect supplementation of the infant. ⋯ ETH Zurich, Switzerland; the Medicor Foundation, Vaduz, Lichtenstein.
-
Lancet Diabetes Endocrinol · Feb 2014
Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study.
Previous studies have yielded conflicting results about the association between incretin therapies and acute pancreatitis. We aimed to compare the occurrence of acute pancreatitis in a population of patients with type 2 diabetes who received incretins compared with those who received other antidiabetic treatment. ⋯ Chaira Medica Association, Chieri, Italy.
-
Lancet Diabetes Endocrinol · Feb 2014
Randomized Controlled TrialMetformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
Metformin reduces cardiovascular risk in patients with type 2 diabetes seemingly independent of lowering blood glucose concentration. We assessed the cardiovascular effects of metformin in individuals without type 2 diabetes. ⋯ Chief Scientist Office (Scotland).